These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8292296)

  • 21. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of infused cardiac natriuretic peptides in myocardial infarction.
    Richards AM
    Heart; 2009 Aug; 95(16):1299-300. PubMed ID: 19447834
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathophysiology and clinical spectrum of acute congestive heart failure.
    Shah M; Ali V; Lamba S; Abraham WT
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S2-6. PubMed ID: 12439355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recommendations for the clinical use of cardiac natriuretic peptides].
    Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G
    Ital Heart J Suppl; 2005 May; 6(5):308-25. PubMed ID: 15934430
    [No Abstract]   [Full Text] [Related]  

  • 25. [Atrial natriuretic factor: a versatile hormone produced by the heart].
    van der Laarse A; Weijers E; Adipranoto J; Manger Cats V; Bruschke AV
    Ned Tijdschr Geneeskd; 1987 Feb; 131(9):353-8. PubMed ID: 3031517
    [No Abstract]   [Full Text] [Related]  

  • 26. Recommendations for the clinical use of cardiac natriuretic peptides.
    Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G; ; ; ; ; ;
    Ital Heart J; 2005 May; 6(5):430-46. PubMed ID: 15934421
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure.
    Hwang GS; Oh KS; Koo HN; Seo HW; You KH; Lee BH
    Eur J Pharmacol; 2006 Jul; 540(1-3):131-8. PubMed ID: 16729997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic treatment with trimetazidine reduces the upregulation of atrial natriuretic peptide in heart failure.
    Morgan EE; Young ME; McElfresh TA; Kung TA; Hoit BD; Chandler MP; Stanley WC
    Fundam Clin Pharmacol; 2006 Oct; 20(5):503-5. PubMed ID: 16968422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathophysiology of congestive heart failure].
    Luzza F; Bruni F; Rizzo F; Carerj S
    Minerva Cardioangiol; 2002 Jun; 50(3):209-19. PubMed ID: 12107401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Natriuretic peptide receptors and heart failure].
    Andreassi MG; Del Ry S; Giannessi D
    Cardiologia; 1999 Mar; 44(3):241-8. PubMed ID: 10327725
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal effects of brain natriuretic peptide in patients with congestive heart failure.
    Jensen KT; Eiskjaer H; Carstens J; Pedersen EB
    Clin Sci (Lond); 1999 Jan; 96(1):5-15. PubMed ID: 9857101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure.
    Yoshimura M; Yasue H; Ogawa H
    Can J Physiol Pharmacol; 2001 Aug; 79(8):730-5. PubMed ID: 11558682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurohormonal activity in heart insufficiency].
    Svanegaard J; Johansen JB; Thayssen P; Haghfelt T
    Ugeskr Laeger; 1993 Jun; 155(23):1784-8. PubMed ID: 8317027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of natriuretic peptides in heart failure].
    Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
    Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the natriuretic peptide system in heart failure: from bench to bedside?
    Schmitt M; Cockcroft JR; Frenneaux MP
    Clin Sci (Lond); 2003 Aug; 105(2):141-60. PubMed ID: 12710884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atrial natriuretic peptides: a new diagnostic tool for the internist].
    Boari B; Manfredini R; Fellin R
    Recenti Prog Med; 2005 Jun; 96(6):300-10. PubMed ID: 16078761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients.
    Hammerer-Lercher A; Puschendorf B; Mair J
    Clin Lab; 2001; 47(5-6):265-77. PubMed ID: 11405605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.